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Abstract
Previous studies with alcohol-associated malondialdehyde–acetaldehyde (MAA)-modified proteins have demonstrated an increase in
the expression of adhesion molecules, and the secretion of pro-inflammatory cytokines/chemokines by rat sinusoidal liver endothelial
cells (SECs). However, no studies have been initiated to examine the effects of MAA-modified proteins on the expression of the
extracellular matrix (ECM) protein, fibronectin and its isoforms. For these studies, SECs were isolated from the liver of normal rats, and
exposed to MAA-modified bovine serum albumin (MAA–Alb). At selected time points, the total plasma and cellular fibronectin were
determined by Western blot. Injection of rat liver via the mesenteric vein with MAA–Alb was performed in an effort to evaluate the
potential in vivo role of MAA-modified proteins in the development of fibrosis. Expression of both plasma and cellular fibronectin was
significantly increased over controls in the MAA–Alb stimulated SECs (>3-fold). Importantly, the isotype of fibronectin secreted was
determined to be of the EIIIA variant and not EIIIB. These data were confirmed using RT-PCR procedures on liver tissue from; isolated
SECs, and from an in vivo animal model wherein MAA–Alb was administered via the mesenteric vein. Thus, these studies demonstrate
that MAA-modified proteins initiate a pro-fibrogenic response by initiating the expression of the fibronectin EIIIA isoform by SECs.
# 2005 Elsevier Inc. All rights reserved.
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1. Introduction
The sinusoidal endothelial cells (SECs) that line the
blood vessels in the liver play a key role in the process of
hepatic fibrogenesis that follows liver injury. The ability of
SECs to react to a stimulus by the release of fibronectin and
subsequently activate stellate cells makes them essential to
the wound healing process [1,2]. Alcohol is a known
hepatotoxin that has been shown to cause severe damage
to the liver and increase liver fibrogenesis [3–6]. Metabolic
byproducts of alcohol metabolism (acetaldehyde and mal-
ondialdehyde) can bind to proteins and form stable
adducts, which have been known to cause many deleterious
effects on various cells of the liver [7–10]. The ability of
malondialdehyde and acetaldehyde to react with proteins
to form the stable hybrid adduct (MAA) [11] has profound
implications in the onset of alcoholic liver disease [12].
The MAA-adduct has been shown to cause the release of
cytokines/chemokines by SECs, KCs, and stellate cells
www.elsevier.com/locate/biochempharm
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[13–15]. It is known that cytokines, growth factors, hor-
mones, and enzymes are present in their inactive form and
upon activation, can alter the ECM and initiate the fibro-
genic process [16]. TheMAA-adduct has been found in the
serum of alcohol-induced cirrhosis and hepatitis patients
and rats chronically consuming alcohol [12,17].
The extracellular matrix (ECM) of the liver is comprised
of many complex molecules that work together to maintain
structural coherence between the cells. While this is one of
the major functions of the ECM, it also modulates other
biological functions,which include cell proliferation,migra-
tion, differentiation, and gene expression in concert with
numerous growth factors, hormones, enzymes, and cyto-
kines [18]. Components of the ECM, including collagen,
glycoproteins, and proteoglycans, may be increased 3–5-
fold upon injury to the liver [19]. Once the liver is injured,
pro-inflammatory, and pro-fibrogenic cytokines are released
by Kupffer (KC), and sinusoidal endothelial cells, resulting
in the recruitmentandactivationof immunecells, an increase
in ECM proteins, and the subsequent repair of the liver.
Fibronectin release by SECs is involved in the initiation
of the process of fibrogenesis in that it is one of the earliest
ECM components expressed in the liver following injury
[2,20]. This was demonstrated using bile duct ligation as a
model of liver injury, where all the individual cells of the
liver were isolated and tested for expression of EIIIA and
EIIIB splice variants. It was found that the greatest quantity
of fibronectin was found in the SECs, which consisted
mostly of the EIIIA variant. The EIIIB variant, after liver
injury, was found to be localized in the lipocytes and not
the SECs. While an important product in the wound
healing process, EIIIB shows up later on in the repair
process. Deposition of the EIIIA variant by injured SECs
was capable of activating stellate cells in an in vitro assay,
which caused the release of type IV collagen [2]. There-
fore, it was the purpose of this study to determine if MAA-
adducted proteins stimulate SECs to increase the synthesis
of the EIIIA fibronectin splice variant.
2. Materials and methods
2.1. Rats
Male Wistar rats were obtained from the National
Cancer Institute and maintained on Purina rat chow diet
until sacrificed. All procedures were approved by the
animal subcommittee of the Omaha VA Medical Center
(accredited by American Association for the Accreditation
of Laboratory Animal, AAALAC) and were in accordance
with guidelines of the National Institutes of Health (1985).
2.2. Chemicals and proteins
Bovine serum albumin (Alb) and fibronectin were pur-
chased from CalBiochem (La Jolla, CA). Acetaldehyde
(AA) was obtained from Aldrich Chemical Co. (Milwau-
kee, WI). Malondialdehyde (MDA) was obtained as the
sodium salt (MDA  Na) by treatment of tetramethoxy-
propane (Aldrich Chemical Co.) with NaOH, according to
the method of Kikugawa and Ido [21]. Lipopolysaccharide
(LPS), phytic acid (PA), and diethylenetriaminepentaacetic
acid (DTPA), transforming growth factor-beta (TGF-b),
interlukin-1 beta (IL-1 b), and Percoll were purchased
from Sigma Chemical Co. (St. Louis, MO). Rat liver
cytosol was isolated by ultracentrifugation methods pre-
viously reported [22].
2.3. Preparation and labeling of ligands
Bovine serum albumin–MAA (MAA–Alb) or liver cyto-
sol–MAA (MAA–cytosol) was prepared by reacting
1.0 mM AA and 2.0 mM MDAwith 30 mM bovine serum
albumin or rat liver cytosol in 0.1 M phosphate buffer pH
7.2, containing 2 mM DTPA and 2 mM PA at 37 8C for 3
days, followed by dialysis against three changes of 0.1 M
sodium phosphate buffer for 24 h at 4 8C [11]. Modified
protein concentrations were determined using the BCA
protein assay from (Pierce, Rockford, IL) and diluted to 10
or 25 mg/ml depending on the assay.
2.4. Isolation of liver sinusoidal endothelial cells
Liver sinusoidal endothelial cells were prepared by
perfusion and differential centrifugation methods as
described previously [23,24]. Briefly, following isolation
cells were counted on a hemocytometer and the viability
was determined by trypan blue exclusion, and found to be
greater than 85% viable. SEC purity was assessed by
staining with antibodies specific for the various cell types
of the liver using a Fluorescent Activated Cell Scanner
(FACSCalibur, San Jose, CA) as previously reported [13].
SECs were determined to be >90% pure.
2.5. MAA–Alb stimulation of SECs
SECs from chow-fed rats were plated on 24 well plates
coated with collagen IV and incubated at 37 8C. After
24 h of incubation, the cells reached confluency, were
washed with 10% M199/F12 and stimulated with media
only, 25 mg/ml Alb, 25 mg/ml MAA–Alb, 5 ng/ml IL-1
b, 10 mg/ml LPS, and 2 ng/ml TGF-b. SECs were incu-
bated overnight, supernatants collected and frozen at
70 8C. The cells were washed with Dulbecco’s phos-
phate buffed saline (D-PBS) and lysed with 2% reduced
(0.5 M 2-ME) sample buffer for use in Western blot
experiments.
2.6. Determination of soluble total fibronectin
Supernatants were assayed for soluble fibronectin using
an inhibition ELISA. Briefly, 96-well ELISA plates
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(Immulon 4 HBX, Thermo Labsystems, Franklin, MA)
were coated with 200 ng/well of rat plasma fibronectin
(Calbiochem, San Diego, CA) in bicarbonate buffer (pH
9.6) and incubated at 4 8C overnight. In 0.5 ml RIA vials,
supernatants and rat plasma fibronectin standard were
mixed with rabbit anti-rat fibronectin (Calbiochem) in
phosphate-buffered saline containing 0.05% Tween 20
(PBST) at a dilution of 1:5000 and incubated overnight
at 4 8C. The plate coated with fibronectin was washed with
PBST and blocked with 2% Alb for 30 min. Supernatant
and the fibronectin standard were transferred to the fibro-
nectin-coated plate and incubated at room temperature for
2 h. Plates were washed with PBST, alkaline phosphatase
goat anti-rabbit IgG (H&L) (Zymed Laboratories, San
Francisco, CA) was added, and the plate was incubated
for 1 h at room temperature. After washing with PBST, p-
nitrophenyl phosphate substrate (Sigma) was added and
absorbency detected by a Dynatech MicroELISA Reader
MR7000 (Dynatech, Chantilly, VA) at 410 nm. Data were
determined by extrapolation from a fibronectin standard
curve and calculated using Biolinx Software (Dynatech).
2.7. Determination of cellular fibronectin and splice
variants
Cell lysate total protein was determined by the BCA
protein assay (Pierce). The protein concentration in each
sample was adjusted to 50 mg/ml and electrophoresed in
precast 4–15% SDS polyacrylamide gradient gels
(BioRad, Hercules, CA) in the presence of sodium dodecyl
sulfate (SDS-PAGE). The proteins were then transferred
onto immobilon PVDF membranes (Millipore, Billerica,
MA) overnight using a wet mini-transblotter (BioRad). To
determine the presence of total cellular fibronectin, blots
were blocked with 2% milk in PBST and incubated with
rabbit anti-rat fibronectin (Calbiochem) at a dilution of
1:1000 overnight at 4 8C. A 1–50,000 dilution of HRP
conjugated goat anti-rabbit IgG (Sigma) was used to detect
the primary antibody and the HRP detected by ECL
(Amersham, England). Gel bands were quantified using
SigmaGel (Jandel Scientific, 2002) and protein size deter-
mined using molecular weight standards from (BioRad)
and a positive total fibronectin control.
In order to determine EIIIA and EIIIB splice variants,
cell lysates were electrophoresed and blotted as described
above. Splice variants were assayed for by using the
antibodies to mouse anti-cellular fibronectin (cFn) mono-
clonal (Clone DH1) EIIIA specific (ICN Biomedicals,
Inc., Aurora, OH) at a dilution of 1:1000 and mouse anti-
human fibronectin III-15 monoclonal antibody EIIIB
specific (Chemicon International, Inc., Temecula, CA)
at a dilution of 1:1000. Detection of the primary antibody
was determined by HRP goat anti-mouse IgG 1:50,000
(Sigma) and autoradiography using ECL (Amersham,
England).
2.8. Rat mesenteric vein injection of modified proteins
Chow-fed rats were subjected to surgery in order to
isolate the mesenteric vein for injection. Prior to surgery,
rats were fasted for 2 h, and then anesthetized with iso-
flurane. Using aseptic technique, the abdominal cavity was
opened and the stomach and intestines placed on sterile
gauze. The mesenteric vein was located and injected with
0.5 ml of PBS, Alb (500 mg), MAA–Alb (500 mg), or sham
(gut was subjected to similar handling). The mesenteric
vein was allowed to clot, the bowel replaced into the
abdominal cavity, and the peritoneal cavity closed with
sutures and staples. Rats were watched until awake and
allowed ad libitum access to food and water overnight.
After 16 h the animals were sacrificed, the liver flushed
with saline, removed, and SECs isolated as outlined above.
As a positive control, a 70% partial hepatectomy was
performed as previously described for liver regeneration
[25,26], providing a proven method of fibronectin synth-
esis. The excised normal tissue served as the negative
control for all reverse transcriptase polymerase chain
reaction (RT-PCR) experiments.
2.9. RNA extraction and reverse transcriptase
polymerase chain reaction
RNAwas extracted from whole liver and isolated SECs
using an RNeasy Mini Kit per the Qiagen protocol (Qia-
gen, Valencia, CA). RNA was quantified and integrity
verified by electrophoresis of 1 mg RNA on a 1% agarose
gel stained with ethidium bromide. Gel bands were
detected by exposure on a Flour-S multiimager and ana-
lyzed by Quantity One software (Bio-Rad). RT-PCR pro-
cedures were performed using a Qiagen one-step RT-PCR
reaction kit. Briefly, 1 mg of RNA was mixed with dNTP
and enzyme supplied by Qiagen with each set of primers to
a final concentration of 1 mM. Primers used in this study
(EIIIA, EIIIB, and GAPDH) were designed by Caputi et al.
[25] and synthesized by Integrated DNATechnologies, Inc.
(IDT, Coralville, IA). Amplifications were performed
using an Eppendorf Mastercycler Personal (Brinkman,
Westbury, NY) using the following cycles; denaturation
(1 min, at 94 8C), annealing (1 min, at 56 8C), extension
(1 min, at 72 8C), which were carried out for 25 amplifica-
tion cycles. PCR products were analyzed by electrophor-
esis in 1% agarose containing ethidium bromide. Fragment
size was verified using a 100 bp DNA ladder standard
(New England BioLabs, Beverly, MA) and gels exposed as
described above.
2.10. Statistical analysis
Results are expressed as means  S.E.M. Statistical
significance was achieved if P-values were less than
0.05. All statistical analysis was performed using ANOVA
in SigmaStat (Jandel Scientific, 2002).
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3. Results
3.1. Soluble fibronectin release in response to
MAA–Alb
In order to determine the ability of MAA–Alb to sti-
mulate isolated SECs to release soluble fibronectin, SECs
were isolated from chow-fed rats and incubated overnight.
These isolated SECs were stimulated with either MAA-
modified albumin or the appropriate positive and negative
controls described in Section 2. SECs stimulated with
media or Alb were tested by ELISA and shown to have
an average of 300–500 mg/ml of soluble fibronectin
(Fig. 1), while MAA–Alb caused a 2–3-fold increase to
1100 mg/ml (P < 0.001). Similar results of MAA–Alb
stimulation were observed with the positive controls IL-
1 b (1200 mg/ml) and TGF-b (1100 mg/ml). LPS (500 mg/
ml) stimulation of SECs had only background levels
similar to that of media only or Alb.
3.2. MAA–Alb-induced cellular and splice variant
fibronectin expression
To investigate the expression of cellular fibronectin after
MAA–Alb incubation, SECs from the above experiments
were washed, solublized in reducing sample buffer, elec-
trophoresed by SDS-PAGE, blotted to immobilon paper,
and stained for the presence of total fibronectin and the
splice variants EIIIA/EIIIB as described in Section 2. Fig. 2
shows strong reactivity to total cellular fibronectin in SECs
stimulated with MAA–cytosol (6146  410) and MAA–
Alb (10,325  481), whereas minimal reactivity was
observed from the SECs stimulated with media only,
Alb, and unmodified liver cytosol (202  102). Reactivity
to the positive fibronectin control showed a density of
(8654  855). The fibronectin bands were present as a
doublet at 200 and 220 kDa as has been previously reported
[27,28].
In order to determine the presence of splice variants of
fibronectin, SEC lysates from the above samples were
subjected toWestern blot using antibodies specific for EIIIA
and EIIIB as described in Section 2. As shown in Fig. 3,
when SECs are stimulated with media only or Alb (10 or
25 mg/ml) there was little expression of the EIIIA variant
doublet (361  42) or (1452  179) and no expression of
EIIIB. However, when SECs were stimulated with MAA–
Alb (10 or 25 mg/ml) or TGF-b a strong increase of the
EIIIAvariantwas observed (5515  358) or (14,331  533)
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Fig. 1. Soluble fibronectin release from isolated SECs stimulated with
MAA–Alb. SECs were isolated from chow-fed rats and stimulated with
media only, Alb, IL-1 b, LPS, and TGF-b overnight at 37 8C. Supernatant
was collected and assayed for soluble fibronectin using an inhibition
ELISA. Results indicate a 2-fold increase in fibronectin released after
stimulation with MAA–Alb, comparable to that of the positive controls
IL-1 b and TGF-b. Background responses were observed when media only,
Alb, and LPS were used as the stimulating ligands. Each bar is the
mean  S.D. of six experiments. Values significantly different from controls
(Alb or media only) are indicated at *P < 0.001.
Fig. 2. Cellular fibronectin release from isolated SECs stimulated with
MAA–Alb. SECs were isolated from chow-fed rats and stimulated with
media only, Alb, liver cytosol, MAA–cytosol, and MAA–Alb. Western blot
analysis for cellular fibronectin shows strong reactivity to the MAA–cytosol
(6146  410) and MAA–Alb (10325  481) stimulated SECs. This was
similar to the positive fibronectin control expression (8654  855). No
responsewas observed whenmedia only, Alb, and liver cytosol were used as
the ligand. Data representative of fivemals under the same conditions and
were quantified by densitometry.
Fig. 3. Fibronectin splice variant expression from isolated SECs stimulated
withMAA–Alb. SECs were isolated from chow-fed rats and stimulated with
media only, Alb at 10 and 25 mg/ml, MAA–Alb at 10 and 25 mg/ml, and
TGF-b. Western blot analysis for the EIIIA variant demonstrated a strong
increase in expression when SECs were stimulated with the 10 mg/ml
MAA–Alb (5515  358) and TGF-b (9708  723). When MAA–Alb
stimulation was increased to 25 mg/ml EIIIA expression increased
(14,331  533). Small background reactivity was noted when media only
or Alb (1452  179) were used as the ligand. No reactivity was shown for
the EIIIB splice variant, except in the positive fibronectin control. Data
representative of five animals under the same conditions and were quantified
by densitometry.
and (9708  723) when TGF-b was used as a positive
control. As a control on the gel, total fibronectin showed
similar banding patterns and reactivity was increased
(8516  885). No signal for the EIIIB variant was seen
after stimulation of SECs with any of the various ligands.
3.3. RT-PCR analysis for splice variants
In order to further demonstrate the expression of the
EIIIA splice variant, RNA was isolated from SECs stimu-
lated with 25 mg/ml Alb or MAA–Alb, and media for 16 h.
An increase in the expression of the EIIIA variant is
represented by a band at 470 bp, while the presence of a
band at 200 bp represents the expression of the normal/
cellular fibronectin. Similarly, the EIIIB variant expresses
two bands (543 and 270 bp). These data showed an ampli-
fication of both the EIIIA, at (200 bp), and EIIIB, at
(270 bp), variant for all the stimuli (Fig. 4). However,
MAA–Alb stimulation of SECs was the only ligand to
initiate the increased expression of the EIIIA+ (470 bp)
variant. No EIIIB+ (543 bp) variant expression was
detected, and the GAPDH control was positive for the
presence of quality RNA. The expression of the EIIIA and
EIIIB variants is consistent with what others have observed
after a 16–24 h incubation following partial hepatectomy
[25]. Data from these sets of experiments show evidence
that isolated SECs can increase fibronectin expression in
vitro after MAA–Alb stimulation.
3.4. In vivo MAA–Alb mesenteric injection
All experiments utilizing isolated SECs have an inherent
problem with high backgrounds due to the non-specific
activation of SECs during their isolation and culture pro-
cess. This was addressed by developing an in vivo model of
SEC activation. Briefly, animals were injected with the
various ligands Alb (500 mg/ml), MAA–Alb (500 mg/ml),
and D-PBS through the mesenteric vein as described in
Section 2. After a 16-h incubation period the liver was
removed and RNA isolated. As a positive control, a 70%
partial hepatectomy was performed and the regenerating
tissue evaluated at the same time as the other livers [25].
RT-PCR was performed using primers specific to EIIIA,
EIIIB, and GAPDH, and the products electrophoresed in
1% agarose gel. Fig. 5 shows the expression of the EIIIA
(200 bp) and EIIIB (270 bp) variants for all the injected
ligands. There was no expression of the EIIIB+ (543 bp)
product for the negative control, any of the injected ligands
or the partial heptectomy. However, there was an increase
in the EIIIA+ (470 bp) variant in the liver injected with
MAA–Alb and the partial hepatectomy treatments. The
GAPDH positive control was present for all the experi-
mental conditions. PBS-injected animals show that the
stress of the surgery and the vehicle itself were not
sufficient to cause changes in the fibronectin expression
of the liver. These data indicate that MAA–Alb affects the
liver and causes the secretion of the EIIIA+ splice variant,
which may contribute to the fibrogenic response.
Finally, in order to determine the involvement of SECs
in this protein adduct-mediated process, chow-fed rats
were injected via the mesenteric vein with Alb (500 mg/
ml), MAA–Alb (500 mg/ml), and PBS. Animals were
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Fig. 4. RT-PCR analysis of splice variants in isolated SECs stimulated in
vitro with MAA–Alb. SECs from chow-fed rats were isolated and stimu-
lated with Alb, MAA–Alb, and media only. RNAwas isolated as described
in Section 2 and amplified for EIIIA and EIIIB fibronectin splice variants.
Expression was observed (200 bp) for the EIIIA variant with Alb, MAA–
Alb, and media only. However, only MAA–Alb stimulation caused the
expression of the EIIIA+ variant at (470 bp). EIIIB expression was detected
in all samples (270 bp). However, no expression was detected for EIIIB+
(543 bp). Gels are representative of SEC RNA from six animals stimulated
with the same ligand.
Fig. 5. Expression of EIIIA+ variant after mesenteric vein injection of
MAA–Alb. Alb (1), MAA–Alb (2), or PBS (3) was injected via the
mesenteric vein of chow-fed rats, incubated for 16 h, RNA from whole
liver isolated, and RT-PCR performed for EIIIA and EIIIB expression. Lane
(4) represents the normal liver and lane (5) a partial hepatectomy as the
positive control. Expression of the 470 bp EIIIA+ variant was observed in
the livers from animals injected with MAA–Alb, and the partial hepatect-
omy control. No expression was seen in the livers of animals injected with
Alb, PBS, or the control liver from the partial hepatectomy. Gels are
representative of five animals injected with the above ligands.
allowed to sit overnight, the liver excised, and the SECs
isolated. RT-PCR data from the isolated SECs are shown in
Fig. 6. As seen in the whole liver extract data, EIIIA+
variant is only increased in the MAA–Alb injected animals
and not in any of the control groups. These data demon-
strate that SECs initiate the production of the EIIIA+
fibronectin variant following exposure to MAA-modified
proteins in vivo. These data are consistent with those
reported by Jarnagin et al. [2] using the bile duct ligation
as a model of liver injury and emphasize the role of SECs in
potentially mediating liver damage.
4. Discussion
There are numerous insults that will initiate enough
damage to the liver to cause fibrosis including physical,
chemical, viral, and immunological agents [29]. Ethanol is
one chemical that often results in the onset of fibrosis
leading to significant liver dysfunction and failure [30]. A
major consequence of ethanol metabolism is lipid perox-
idation, which results in the production of the aldehydic
end products, 4-hydroxy-nonenal and malondiadehyde
[31–33]. Another metabolic product of ethanol consump-
tion is acetaldehyde, which is also produced in the liver,
and has been shown to interact with malondialdehyde to
form the stable protein adduct called malondialdehyde–
acetaldehyde-adduct (MAA) [11]. Antibodies to theMAA-
adduct have been found in the serum of patients diagnosed
with alcohol-induced cirrhosis and hepatitis, and rats
chronically consuming alcohol [12,17]. Therefore, it was
the purpose of this study to determine if MAA-adducted
proteins will stimulate SECs to increase the synthesis of
fibronectin and/or initiate the conversion of fibronectin to
the fibronectin EIIIA+ isotype.
Previous studies in our laboratory have shown the
induction by MAA-adducts of pro-inflammatory cyto-
kines/chemokines and adhesion molecules [13,15]. An
increase in fibronectin secretion by SECs of the liver in
response to MAA-adduct stimulation may be one method
by which chronic alcohol consumption induces fibrosis
leading to cirrhosis. In this study, the SECs from the livers
of chow-fed rats exposed to MAA–Alb increased their
secretion of soluble fibronectin 2–3-fold over the Alb
control, which is comparable to the IL-1 b and TGF-b
positive controls. When Western blot analysis was per-
formed on these SECs, similar results were observed for
cellular fibronectin expression. These blots demonstrated
an increased expression in SECs exposed toMAA–Alb and
MAA–cytosol.
It has been shown that de novo synthesis of EIIIA, a
splice variant of cellular fibronectin, by stimulated
endothelial cells can activate hepatic stellate cells [2].
To show that MAA-adducts may increase the expression
of the EIIIAvariant, SECs were exposed to MAA–Alb, and
Western blots were performed using antibodies specific for
EIIIA and EIIIB. Expression of the EIIIA variant was
found to be increased over background in the MAA–Alb
stimulated SECs and was increased with a higher concen-
tration of the ligand. Expression of EIIIA was slightly
higher in the MAA–Alb stimulated SECs when compared
to the positive control stimulus TGF-b. The expression of
EIIIB was not observed for all the ligands used in these
studies. These Western blot studies were confirmed by RT-
PCR that was performed in order to assess the expression
of EIIIA. Using this method it was possible to show that
only the MAA–Alb exposed SECs increased the expres-
sion of the EIIIA+ variant at 470 bp. No expression of the
EIIIB variant was observed under these conditions.
All studies utilizing isolated SECs in in vitro assays have
inherent weaknesses. Firstly, the physical process of
separation and culture in itself activates SECs, raising
baseline levels of cytokine secretion that are not observed
in vivo. Secondly, isolated SECs interact with soluble
ligands under the non-physiological conditions of isolated
cells. Removal from the extracellular matrix, cell-to-cell
contact, and immediate exposure to cytokines from adja-
cent cells may well alter both the qualitative and quanti-
tative responses to ligand stimulation. Because of these
potential limitations, and in order to further demonstrate
that MAA-adducts play a role in these processes an in vivo
model was developed, wherein MAA-adducts were
injected through the mesenteric vein which directly drains
to the liver. These studies confirmed the findings utilizing
stimulated isolated SECs and again demonstrated that
MAA-modified albumin induced a substantial increase
in EIIIA+ expression. The expression of the EIIIB+ variant
was negative for all the experimental conditions.
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Fig. 6. Expression of EIIIA+ variant in SECs following mesenteric
vein injection of MAA–Alb. Chow-fed rats were injected via the mesen-
teric vein with PBS, Alb, and MAA–Alb, incubated for 16 h, SECs
isolated, RNA purified, and RT-PCR performed for EIIIA and EIIIB
splice variant expression. Expression of the EIIIA+ (470 bp) variant was
evident in only the SECs from livers injected with MAA–Alb. Expression
of EIIIB+ was negative in the SECs from livers injected with PBS, Alb,
and MAA–Alb. Gels are representative of five animals injected with the
above ligands.
The role of SECs in the whole liver in vivo model was
confirmed by isolating the SECs from the liver after ligand
injection through the mesenteric vein, and demonstrating
by RT-PCR that the EIIIA+ isoform was upregulated.
These data demonstrated that animals injected with
MAA–Alb and not the Alb or PBS controls were respon-
sible for the increase in EIIIA+ expression. While these
studies do not rule out the involvement of other hepatic cell
types, this data strongly suggest that the SECs play a major
role in this response.
The pathogenesis of fibrosis leading to cirrhosis involves
a complex series of events [1]. Recently, it has been shown
that hepatic fibrosis is a wound-healing response that
occurs following chronic liver injury and is similar to what
occurs in the lung, kidney, heart or skin. This observation
has allowed investigators across many disciplines to share
their data and advance this field significantly. In the liver,
myofibroblast-like cells come from activated stellate cells.
Initially, it appears that the subendothelial deposition of
cellular fibronectin in the Space of Disse by sinusoidal
endothelial cells provokes stellate cell activation [2,30].
The activation of resident stellate cells causes them to
increase in number, degrade broken down matrix proteins,
and enhance fibrogenesis by making new extra-cellular
matrix components [1]. Under normal conditions, the
products that activate stellate cells are removed, the liver
heals and homeostasis is restored.
However, under various circumstances wherein stellate
cells remain activated, then the increased production of
fibril-forming matrix could lead to the loss of function by
hepatocytes and reduced sinusoidal cell porosity, and
eventually fibrosis and/or cirrhosis. One such mechanism
that could result in the continuous stimulation of stellate
cells is the release of fibronectin by SECs following
exposure to MAA-modified proteins. Indeed, in this study
it was shown that isolated SECs when incubated with
MAA-modified proteins not only secreted both soluble
and cellular fibronectin, but also the EIIIAvariant which is
believed to be involved in the activation of stellate cells [2].
Further studies need to be performed in order to determine
if these soluble products secreted by SECs in response to
MAA-modified proteins can induce stellate cells to pro-
duce extra-cellular matrices, which contribute to the devel-
opment of fibrosis and cirrhosis. Regardless, these studies
strongly suggest an interaction between MAA-modified
proteins and SECs in the development and/or progression
of alcoholic liver disease.
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